TITLE:

APBI: NICE recommends to maintain medicines access for patients with severe rheumatoid arthritis

BRIEF:

 The ABPI welcomes the publication of the National Institute of Health and Care Excellence (NICE) final appraisal determination (FAD) for rheumatoid arthritis which recommends continued access to biologic medicines for patients living with severe rheumatoid arthritis.